Pharmaceuticals News

Subscribe to pharmaceutical news about research, development, manufacturing and marketing of prescription and over the counter drugs. Find the latest on FDA approvals, compliance, competition, management and distribution of pharmaceutical products as well as pharmaceutical business intelligence.

Frost & Sullivan: Diagnostic and Therapeutic Potential of microRNAs Stimulate Need for More Research Tools

Product innovation and the development of high-qualitative assays are the need of the hour. - September 05, 2013 - Frost & Sullivan

CHI Interviews Janet L. Lathey, Ph.D of Emergent BioSolutions on Optimizing Bioassays for Biologics

Janet L. Lathey, Ph.D., Director, Immunology and Assay Development, BioDefense Division, Emergent BioSolutions sits down with conference producer Samantha Lewis to discuss the biggest challenges to managing bioassay variability, new tools and strategies that researchers are using to combat it, and... - August 26, 2013 - Cambridge Healthtech Institute

Recession and Contradiction in the Pharmaceutical Industry in 2013

New report highlights the contradiction at the heart of the pharmaceutical industry in 2013. “Whilst there is increased investment and growth an underlying uncertainty and volatility in the pharmaceutical industry has made investors cautious.” -Pharma IQ Recession Report. - August 22, 2013 - IQPC

BaseCase Launches Closed Loop Marketing for Market Access

Value communication and technology firm BaseCase have announced the launch this week of their closed loop marketing (CLM) solution for market access. - August 22, 2013 - BaseCase

iBeta Completes DEA EPCS Biometric Certification for Lumidigm’s V-Series Fingerprint Devices

iBeta Quality Assurance (“iBeta”), a National Voluntary Laboratory Accreditation Program (NVLAP) accredited Biometrics Testing Laboratory, and DEA-approved EPCS Biometric Certification Lab has completed one of the first DEA EPCS biometric certifications for a series of fingerprint... - August 13, 2013 - iBeta Quality Assurance

FDAnews Webinar — Cosmetics Warning Letters Detail Rash of Problems; Webinar Provides Solutions

Is It a Cosmetic, a Drug or Both? 15-Year Regulatory Veteran Shares Compliance Secrets Presented by FDAnews Aug. 23, 2013 • 1:30 p.m. – 3:00 p.m. EDT http://www.fdanews.com/CosmeticsWebinarPR2 - August 11, 2013 - FDAnews

Innovus Launches New Corporate Website

Innovus Pharmaceuticals, Inc., ("Innovus Pharma") www.innovuspharma.com (OTC: BB: INNV) announced today it has launched a newly designed corporate website. The new website reflects the values and mission of the company and contains updated content on our current product portfolio and... - August 08, 2013 - Innovus Pharmaceuticals, Inc.

G-Mycin Studio LLC launches PortScript App for Independent Pharmacies Patients

Independent pharmacies customers now have easy access to their pharmacies with the launch of PortScript App. - August 07, 2013 - G-Mycin Studio LLC

New Exchangeable Turbine Flow Sensor Ideal for Low Flow Pharmaceutical and Industrial Applications

Clark Solutions’ PFAD Disposable Turbine Flow Sensor is designed for applications with flow rates of .06 lpm to 20 lpm, accuracy 1% of reading. PFAD Flow Sensors feature an easy-to-replace, ultra-lightweight turbine assembly. - August 06, 2013 - Clark Solutions

Dataline Launches Web Based Solution for Clinical Trials

Novo Nordisk is a world leader in diabetes care and continuously carries out clinical research programmes in its endeavour to develop new and effective treatments. These programmes currently involve over 2,000 UK diabetes patients - volunteers - in clinical trials every year at around 100 UK study... - August 02, 2013 - Dataline Software

AveXis Inc. Names Chief Scientific Officer

AveXis Inc. (avexisinc.com), a synthetic biology platform company focused on research and development of technology for disease treatment, today announced Dr. Allan A. Kaspar will serve as the company’s first Chief Scientific Officer (CSO). Dr. Kaspar has held research positions at multiple... - August 01, 2013 - AveXis Inc.

Final Agenda Announced for CHI’s FAST: Functional Analysis & Screening Technologies Congress

Headlined by Karen Burg, DL Taylor, Steve Ludbrook and Aaron Morris, CHI's FAST Congress features three days of innovative presentations for more accurate biological response in drug discovery through novel screening technologies and strategies. - July 27, 2013 - Cambridge Healthtech Institute

ICRC-Weyer to Expand Pharmacovigilance Services for Mid-Sized Pharma Companies

ICRC-Weyer GmbH, a Berlin-based clinical contract research organization, is expanding its pharmacovigilance services for small to mid-sized pharmaceutical companies. - July 24, 2013 - ICRC-Weyer GmbH

OsoBio Appoints Lindsey Pruitt to Manage East Coast Business Development Efforts

Working in her new capacity in OsoBio’s Philadelphia location, Pruitt will identify and foster new business opportunities throughout the Northeast. - July 22, 2013 - OSO BioPharmaceuticals Manufacturing, LLC

KJT Group Hires Director of European Practice

KJT Group, a full service life sciences market research and insight consultancy firm, is pleased to announce the continued growth of its global operations with the hiring of Nicola Guerra, PhD, MSc as the Director of European Practice in its Amsterdam office. - July 17, 2013 - KJT Group

Four Insightful Conferences to be Held at CHI's Fifth Annual Immunogenicity Summit 2013

Technologies and Strategies for Safe and Efficacious Products in the Clinic - July 15, 2013 - Cambridge Healthtech Institute

Activus Solutions, LLC Announces Successful Revitas System Implementation with Leading Generics Manufacturer

Activus Solutions, LLC is proud to announce the successful implementation of the Revitas CARS application at Glenmark Pharmaceuticals. The effort was performed in close collaboration with Revitas, the software vendor and was delivered on-time and under budget. The implementation project was... - July 12, 2013 - Activus Solutions

Chinese Pharma Growth Slows, But with Unchanged Long Term Positive View

The Chinese pharmaceutical industry and market in 2012/2013 was characterized by slowing growth, falling profitability, mixed regulatory developments, renewed price cutting initiatives, superficial healthcare reform progress driven primarily by cost containment measures, fallen healthcare quality, according to China Pharmaceutical Guide 2013 (8th Edition), which was officially published today by WiCON International Group LLC, the publisher of Pharma China. - July 08, 2013 - WiCON International Group LLC

Angela Balian Recognized by Strathmore's Who's Who Worldwide Publication

Angela Balian of Las Vegas, Nevada has been included in the Strathmore’s Who’s Who Worldwide Edition for her outstanding contributions and achievements in the pharmaceutical field. About Angela Balian Dr. Balian has 6 years experience in the pharmaceutical field. She is the Pharmacy... - July 03, 2013 - Strathmore Worldwide

Doctor Evidence and Konnectology Partner to Bring End-to-End Evidence on Medical Treatments: From Clinical Studies to Real World Evidence

With the single common goal of improving patient outcomes, Doctor Evidence and Konnectology today announced their partnership to provide a combination of Real-World Evidence (RWE) and published clinical study evidence on medical treatments. Doctor Evidence and Konnectology’s combined... - June 27, 2013 - Konnectology

OsoBio Names Kathleen Larese Director of Laboratories

OsoBio has named Kathleen Larese director of laboratories. As part of OsoBio’s quality control department, the microbiology and chemistry laboratories that Larese now directs are responsible for environmental monitoring, analytical method development, and testing all incoming raw materials,... - June 26, 2013 - OSO BioPharmaceuticals Manufacturing, LLC

MicroAgility, Inc. Celebrates Its 10th Anniversary with Gratitude

MicroAgility, Inc, an award-winning business and technology consulting company, announced today that it will be commemorating the 10th anniversary of its founding in 2003 with utmost gratitude. “MicroAgility is celebrating ten years of dedication, accomplishment, and partnership with our... - June 17, 2013 - MicroAgility, Inc.

Generic Drugs Market Research Report Submitted by Transparency Market Research

Transparency Market Research Report Adds "Generic Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 - 2018" to its database. - June 13, 2013 - Transparency Market Research

NanCogenics Reports Research Findings on Tumor-Localization of Cancer Therapeutics

Research results on the use of magnetic nanovectors for the tumor-specific localization of cancer therapeutics is discussed. - June 08, 2013 - NanCogenics Inc

Acceliant Gears Up to Showcase Its Capabilities at 4th Annual Clinical Trials Summit, Mumbai

Acceliant, a global technology provider of innovative clinical solutions, gears up for the 4th Annual Clinical Trials Summit. The summit is scheduled on 7th June, 2013 at Kohinoor Continental Hotel, Mumbai. “Acceliant is excited to be participating in the 4th Annual Clinical Trials Summit. - June 07, 2013 - Trianz

Announcing SUSdocs.org, an Unbiased, Vendor-Neutral Website for Information on Single Use/Disposable Systems; Developed for the Bioprocess & Pharmaceutical Industries

SUSdocs.org is a new website devoted to educating and informing viewers about single use/disposable systems used in pharmaceutical and bioprocess applications. The site was developed through the cooperative efforts of several pharma-related associations and suppliers. All documents are impartial, explanatory and intended to help and support the single use systems industry. - June 06, 2013 - NewAge Industries, Inc.

New Team Announcement by Scientific Animations for Indian Market

Scientific Animations have announced a new team to service the needs of the Indian market. Historically, large Indian pharmaceutical companies have produced generics (drugs that are off-patent) where margins are lower and the requirement for cutting edge marketing is less also. - June 05, 2013 - Scientific Animation

ICRC-Weyer to Boost Drug Safety Services for Investigator Trials

The Berlin-based clinical contract research organization (CRO), ICRC-Weyer GmbH, has announced it will boost its drug-safety related Pharmacovigilance Services for Investigator-Initiated Trials amid an increasing demand by trial sponsors. - June 02, 2013 - ICRC-Weyer GmbH

Dr. Dean Bottino, Roche, to Discuss Multi-Scale Modeling in Development of Cancer Drugs in Rosa’s Impact Webinar Series

Dr. Bottino will present the Webinar “Multi-scale modeling to optimize the antitumor effect of antibody-dependent cell-mediated cytotoxicity (ADCC) enhanced therapies” on June 19, 2013. - May 28, 2013 - Rosa & Co LLC

Global Protein and Antibody Engineering Market Research Report Submitted by Transparency Market Research

Transparency Market Research Report Adds "Advances In Protein/Antibody Engineering Market - Global Industry Analysis, Size, Share, Growth, Trends, And Forecast, 2012 - 2018" to its database. - May 22, 2013 - Transparency Market Research

Global Multiple Sclerosis Drugs Market Research Report Submitted by Transparency Market Research

Transparency Market Research Report Ads "Global Multiple Sclerosis Drugs Market - Industry Analysis, Size, Share, Growth, Trends, And Forecast, 2012 - 2018" to its database. - May 17, 2013 - Transparency Market Research

Acceliant to Participate in the 4th Annual Clinical Trials Summit in Mumbai

Acceliant, a global technology provider of innovative clinical solutions, is set to participate in 4th Annual Clinical Trials Summit to be held in Mumbai at Kohinoor Continental Hotel on 7th June, 2013. All the attendees are invited to visit Booth # 3 where Acceliant will showcase its... - May 16, 2013 - Trianz

OsoBio Appoints David M. Lee Vice President of Quality

OsoBio has named David M. Lee vice president of quality. Lee is responsible for overseeing all quality-related functions to ensure the company’s continued compliance with Current Good Manufacturing Practices (cGMP), including quality systems, quality control and manufacturing quality... - May 10, 2013 - OSO BioPharmaceuticals Manufacturing, LLC

4th International Conference and Exhibition on Analytical & Bioanalytical Techniques

OMICS Group invites you to attend the 4th International Conference and Exhibition on Analytical & Bioanalytical Techniques during Oct 15-17, 2013 at Hampton Inn Tropicana, Las Vegas, USA. OMICS Group welcomes all the participants from across the world to take part in this premier event. - May 03, 2013 - OMICS Group Incorporation

LUZ, Inc. Opens Boston Office

Life Science Translation Provider Expands to Northeast. - May 03, 2013 - LUZ, Inc.

2013 Update from Families of Spinal Muscular Atrophy on the SMA Drug Pipeline

15 new drugs now in development for SMA. 3 in active clinical trials. 11 companies investing in SMA drug programs. - May 02, 2013 - Cure SMA

Artcraft Health Education Launches 2 Websites

Artcraft Health Education, a leader in health education solutions, launches websites for clinical trial services and digital services. - May 01, 2013 - Artcraft Health Education

Scientific Animations Announce Launch of iPad Division to Bring High-Quality Visuals

With over 95% of Fortune five hundred companies having either tested or deployed iPads, the iPad app development market is rapidly growing. The medical industry has stayed in lockstep with this trend. After almost a decade of serving the medical industry's graphics and animation needs, Scientific... - May 01, 2013 - Scientific Animation

ALPCO Expands Product Offering with EuroFlow™ Flow Cytometry Reagents and Infinicyt™ Analytical Software from Cytognos S.L.

Starting April 30, 2013 ALPCO will begin offering flow cytometry solutions from Cytognos S.L. - April 30, 2013 - ALPCO

Big Pharma Recession Survey Updated for 2013 – Future Trends Predicted

In 2011, Pharma IQ conducted a global survey to find out how the downturn in the economy had affected the biotech and pharma industry. Over 500 industry professionals took the time to fill in our survey and the results were shocking with nearly 45% of respondents claiming they feared redundancy... - April 28, 2013 - IQPC

Precision Building Construction, LLC Completes New High-Efficiency USP 797 Compliant Cleanroom for Olympia Pharmacy in Orlando, FL

Precision Building Construction, LLC, today announced that it has successfully completed the construction of a new high-efficiency aseptic cleanroom production facility for Olympia Pharmacy in Orlando, FL. To manage the rapid growth in the pharmaceutical compounding and dispensing market, Olympia... - April 26, 2013 - Precision Building Construction, LLC

Herpes Solution Provider, Viradux Research Announces JV Partnership

A new development in the war against genital and oral herpes. - April 26, 2013 - viradux

YaxinBio Launches 2 New Products: Enterokinase and V8 Protease

Shanghai Yaxin Biotechnology Co., Ltd. offers two new recombinant proteins. Recombinant Bovine enterokinase, also known as enteropeptidase, is a specific protease used for tag removal, while V8 Protease (Endoproteinase GluC) is highly important for protein structure and sequence... - April 23, 2013 - Shanghai Yaxin Biotechnology Co. Ltd.

AdvantaPure(R) Now Offers Molded Manifold Connections, Precision Molded from Platinum-Cured Silicone, That Are Guaranteed Not to Leak

AdvantaPure’s molded silicone manifold connections, available in tee, wye, cross and reducer styles, are now guaranteed leak-proof. The company uses only high quality materials, precise manufacturing, and extensive quality controls, resulting in connections that prevent leaks of valuable pharmaceutical and biopharmaceutical fluids. The molded connections also help reduce contamination, uneven inner surfaces, inventoried parts, and risks associated with working with live viruses. - April 17, 2013 - NewAge Industries, Inc.

Metrics Inc. Offers Proprietary Pellet Forms for Advanced Drug Release

Unique pellet formulations help support therapeutic effectiveness of active pharmaceutical ingredients. - April 12, 2013 - Metrics, Inc.

Upcoming Drug Safety Training Opportunities

Don’t Miss Two New Interactive Drug Safety Training Sessions by Dr. Michael J. Klepper, Global Pharmacovigilance Expert, Coming This Spring - April 09, 2013 - Drug Safety Navigator, LLC

Growing Technology Commercialization: University of Kansas Moving Innovation from the Laboratory to the Marketplace

The University of Kansas is moving innovations from the laboratory to the marketplace at breakneck speed. Julie Goonewardene, President of KU Technology Commercialization Center, announced five researchers were awarded $50,000 each to further their research, research includes 1) medical delivery methods; 2) protein-based drugs for Parkinson's Disease; 3) new drugs for multiple sclerosis; 4) slide and tissue block valet system; 5) and solar panel detectors and sensors. - March 26, 2013 - The University of Kansas Center for Technology Commercialization